Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Amgen
CRO
Amgen, Merck join academic clinical trial diversity partnership
Amgen and Merck will co-design strategies to foster closer collaborations and engagements with local trial sites and communities.
Darren Incorvaia
Sep 16, 2024 3:10pm
Viridian eye disease phase 3 hits, advancing push to rival Amgen
Sep 10, 2024 8:10am
Acelyrin loses interest in izokibep, lays off 3rd of staff
Aug 13, 2024 4:00pm
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers
Mar 6, 2024 10:02am